临床试验/NCT01414959

NCT01414959已完成不适用

Target Site Pharmacokinetics of Doripenem at Steady State in Intubated Intensive Care Patients

Medical University of Vienna1 个研究点分布在 1 个国家目标入组 16 人开始时间: 2011年8月最近更新: 2017年8月29日

适应症

试验速览

阶段: 不适用
状态: 已完成
发起方: Medical University of Vienna
入组人数: 16
试验地点: 1

研究概览研究设计入排标准研究者研究点记录与标识符相似试验

研究概览

简要总结

The investigators will measure the pharmacokinetics of doripenem in skeletal muscle, subcutaneous adipose tissue, bronchoalveolar lavage and plasma of intubated intensive care patients.

详细描述

Methods: microdialysis, blood sampling, bronchoalveolar lavage

研究设计

研究类型: Observational
观察模型: Cohort
时间视角: Prospective

入排标准

年龄范围: 18 Years 至 —（Adult, Older Adult）
性别: All
接受健康志愿者: 否

入选标准

•endotracheal intubation; pneumonia or complicated abdominal infection or complicated urinary tract infection

排除标准

•allergy to doripenem, hemodialysis

研究者

发起方

Medical University of Vienna

申办方类型

Other

责任方

Principal Investigator

主要研究者

Markus Zeitlinger

Professor Dr.

Medical University of Vienna

研究点 (1)

Loading locations...

相似试验

进行中（未招募）

1 期

Target site pharmacokinetics of doripenem at steady state in intubated intensive care patients - Dori_MD_IC

EUCTR2011-000035-89-ATMed. Univ. Wien, Klinik für klinische Pharmakologie20

已完成

4 期

Target Site Pharmacokinetics of Doripenem After a Single Dose of 500mg in Healthy Volunteers Dori_MD_1Healthy

NCT01311141Medical University of Vienna6

已完成

1 期

Doripenem Intrapulmonary Pharmacokinetics in Healthy Adult SubjectsHealthy

NCT00925392Keith A. Rodvold40

已完成

4 期

Pharmacokinetic and Pharmacodynamic Evaluation of Doripenem in Critically Ill Trauma PatientsSepsis

NCT01027897Emory University30

已完成

3 期

Multiple-dose Pharmacokinetics of Doripenem During Continuous Venovenous Hemodiafiltration and Molecular Adsorbent Recirculating System in ICU Patients and During Hemodialysis in Longterm Hemodialysis Patients.Infections During Organ Replacement Therapy

NCT02018939Medical University of Vienna24